Searched for
JB PHARMA RESULTS
JB Pharma Q2 Results: Net profit jumps 16% to Rs 175 crore, revenue up 13%JB Pharma reported a 16% YoY increase in Q2FY25 net profit to Rs 175 crore, driven by 22% growth in domestic business. Revenues rose 13% to...07 Nov, 2024, 09.27 PM IST- JB Pharma Q1 Results: Net profit jumps 25% YoY to Rs 177 croreThe drug maker had reported a net profit of Rs 142 crore in the year-ago period.Revenue for the quarter rose 12% YoY to Rs 1004 crore08 Aug, 2024, 09.40 PM IST
- Local pharma companies queue up for JB Chemicals & PharmaceuticalsMankind Pharma, Dr Reddy's Laboratories, and Torrent Pharma are interested in acquiring JB Chemicals & Pharmaceuticals from KKR. KKR's inve...24 May, 2024, 10.31 AM IST
- JB Pharma expects India business to grow above market growth rate in FY25: CEO Nikhil ChopraJB Pharma, led by CEO Nikhil Chopra, forecasts 12-14% revenue growth and aims to increase Ebitda margins by 27-28% in FY25. The growth is d...21 May, 2024, 12.42 AM IST
- JB Pharma Q4 Results: Net profit jumps 43% YoY to Rs 126 croreThe Mumbai-based company reported operating earnings before interest, taxes, depreciation and amortisation (EBITDA) at Rs 210 crore, up fro...17 May, 2024, 10.13 PM IST
- Hot Stocks: Brokerages view on Trent, Nazara Technologies, Nestle and JB PharmaCitigroup maintained a buy rating on Nestle India post Q3 results with a target price of Rs 2900. The company reported steady revenue growt...08 Feb, 2024, 09.37 AM IST
- JB Pharma Q3 Results: Net profit jumps 26% to Rs 134 croreThe drug maker had reported a net profit of Rs 106 crore in the year-ago period. Revenue for the quarter rose 7% YoY to Rs 845 crore The Mu...06 Feb, 2024, 11.32 PM IST
- Hot Stocks: Brokerage view on Prestige Estates, JB Pharma, Uno Minda and Jyothy LabsCitigroup maintained a buy rating on Prestige Estates but raised the target price to Rs 982 from Rs 693 earlier.09 Nov, 2023, 09.23 AM IST
- JB Pharma Q2 Results: Net profit jumps 35% YoY to Rs 151 croreRevenue for the quarter rose 9% YoY to Rs 882 crore. The Mumbai-based company reported operating earnings before interest, taxes, depreciat...07 Nov, 2023, 08.18 PM IST
- JB Pharma Q1 Results: Net profit surges 35% YoY to Rs 142 croreDomestic business revenue grew 17% YoY to Rs 489 crores in Q1FY24, despite sales for the acute business being impacted due to the delayed m...09 Aug, 2023, 07.51 PM IST
- JB Pharma Q3 Results: Net profit rises 26% to Rs 106 croreThe earnings before interest, tax, depreciation and ammortisation (EBITDA) rose 28% YoY to Rs 193 crore. The EBTIDA margin dropped 120 basi...08 Feb, 2023, 08.45 PM IST
- JB Pharma profit rises 13% to Rs 111 crore in Q2FY23Revenues rose 36% YoY to Rs 809 crore in Q2FY23, compared to Rs 593 crore in Q2FY22.Earnings before interest, depreciation and taxes (EBITD...11 Nov, 2022, 09.04 PM IST
- JB Pharma net profit down 12% to Rs 105 croreThe company reported net profit of Rs 119 crore during corresponding period of the previous year.The company attributed the drop in net pro...04 Aug, 2022, 10.33 PM IST
- JB Chemicals & Pharma Q2 results: Net profit up 32% to Rs 98 crConsolidated revenue from operations of the company stood at Rs 593.01 crore for the quarter under consideration. It was Rs 443.56 crore fo...12 Nov, 2021, 01.14 AM IST
- Apax, KKR and PAG in final lap for JB Chemicals buyoutJB Chemicals has a market cap of Rs 5,568 crore. During the last three months, shares of JB Chemicals have gone up 26% on BSE. On Wednesday...11 Jun, 2020, 08.11 AM IST
- High pressure on pharma margins; buy JB Chemicals: SharekhanLupin and Glenmark as clear winners with a likely upside from Para IV/niche opportunities, strong domestic franchise, low vulnerability to ...18 Feb, 2011, 12.48 PM IST
- Domestic pharma companies may see a phase of consolidation: Ajay Parmar, Emkay Global Financial ServicesCompanies having more income from the domestic business can see margins declining.27 Oct, 2010, 04.22 PM IST
Load More
